PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)

PHASE4TerminatedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

July 13, 2009

Primary Completion Date

December 29, 2017

Study Completion Date

March 28, 2018

Conditions
Anterior Ischemic Optic Neuropathy
Interventions
DRUG

Diagnostic procedures

The patients will not receive any study drug in this study. The patients will have ophthalmological (eye) examinations, blood work and will complete an interview

Trial Locations (13)

2000

Save Sight Institute, Sydney

28803

Asheville Eye Associates, Asheville

33461

Palm Beach Eye Center, Atlantis

33908

West Coast Eye Care, Fort Myers

33912

National Ophthalmic Research Institute, Fort Myers

34239

Sarasota Retina Institute, Sarasota

46290

Midwest Eye Institute, Indianapolis

48088

Spoor and Associates, Warren

74014

Tulsa Clinical Research, LLC, Tulsa

77030

Retinal and Ophthalmic Consultants, Houston

92083

Greider Eye Associates, Vista

43215-7312

Office of Dr. Avrom Epstein, MD, Columbus

M5G 1X5

Midwest Eye Institute, Toronto

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Bayer

INDUSTRY